Prelude Capital Management’s Eton Pharmaceutcials ETON Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $621K | Sell |
43,600
-125,836
| -74% | -$1.79M | 0.06% | 380 |
|
|
2025
Q1 | $2.2M | Buy |
169,436
+145,194
| +599% | +$1.88M | 0.17% | 117 |
|
|
2024
Q4 | $323K | Buy |
+24,242
| New | +$323K | 0.02% | 665 |
|
|
2021
Q2 | – | Sell |
-30,905
| Closed | -$226K | – | 1423 |
|
|
2021
Q1 | $226K | Sell |
30,905
-1,056
| -3% | -$7.72K | 0.01% | 890 |
|
|
2020
Q4 | $260K | Buy |
31,961
+11,149
| +54% | +$90.7K | 0.01% | 567 |
|
|
2020
Q3 | $164K | Sell |
20,812
-135,364
| -87% | -$1.07M | 0.01% | 553 |
|
|
2020
Q2 | $851K | Sell |
156,176
-121,521
| -44% | -$662K | 0.05% | 183 |
|
|
2020
Q1 | $1.14M | Buy |
277,697
+149,733
| +117% | +$614K | 0.08% | 89 |
|
|
2019
Q4 | $921K | Buy |
127,964
+54,023
| +73% | +$389K | 0.04% | 210 |
|
|
2019
Q3 | $467K | Buy |
73,941
+18,047
| +32% | +$114K | 0.02% | 285 |
|
|
2019
Q2 | $442K | Buy |
55,894
+19,072
| +52% | +$151K | 0.02% | 304 |
|
|
2019
Q1 | $295K | Buy |
36,822
+11,552
| +46% | +$92.5K | 0.02% | 368 |
|
|
2018
Q4 | $155K | Buy |
+25,270
| New | +$155K | 0.01% | 572 |
|